| For: | Papazafiropoulou AK. Effects of Chios mastic gum on cardiometabolic risk factors. World J Diabetes 2022; 13(11): 921-925 [PMID: 36437867 DOI: 10.4239/wjd.v13.i11.921] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v13/i11/921.htm |
| Number | Citing Articles |
| 1 |
Roberta Ottria, Ornella Xynomilakis, Silvana Casati, Ezio Abbiati, Giovanni Maconi, Pierangela Ciuffreda. Chios Mastic Gum: Chemical Profile and Pharmacological Properties in Inflammatory Bowel Disease: From the Past to the Future. International Journal of Molecular Sciences 2023; 24(15): 12038 doi: 10.3390/ijms241512038
|
| 2 |
Aparna Ganeshkumar, Ram Sabarish, Nadha Shakir, Divya Shree Sankar, Adelyn Jerusha Franklin, Nagalakshmi Gandhi, Kennedy Kumar, Amjad Abu Hasna. In Vitro Evaluation and Network Pharmacology Analysis of the Antimicrobial Activity of Pistacia lentiscus. International Journal of Dentistry 2026; 2026(1) doi: 10.1155/ijod/6981413
|
| 3 |
Sarah A. Blomquist, Maria Luz Fernandez. Chios Mastic Gum: A Promising Phytotherapeutic for Cardiometabolic Health. Nutrients 2024; 16(17): 2941 doi: 10.3390/nu16172941
|
